Bianjiang Liu
Overview
Explore the profile of Bianjiang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cui Y, Zhang S, Miao C, Liang C, Chen X, Yan T, et al.
Transl Androl Urol
. 2021 Sep;
10(8):3317-3331.
PMID: 34532256
Background: Studies over the past decade have shown that long non-coding RNAs (lncRNAs) play an essential role in the tumorigenesis and progression of kidney renal clear cell carcinoma (KIRC). Meanwhile,...
12.
TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner
Miao C, Liang C, Li P, Liu B, Qin C, Yuan H, et al.
J Exp Clin Cancer Res
. 2021 Jun;
40(1):195.
PMID: 34130705
Background: Ubiquitylation modification is one of the multiple post-transcriptional process to regulate cellular physiology, including cell signaling, cycle regulation, DNA repair and transcriptional regulation. Members of TRIM family proteins could...
13.
Liu B, Sun Y, Tang M, Liang C, Huang C, Niu Y, et al.
Cell Death Dis
. 2020 Sep;
11(9):807.
PMID: 32978369
The androgen receptor splicing variant 7 (ARv7) that lacks the ligand-binding domain is increasingly considered as a key player leading to enzalutamide (Enz) resistance in patients with prostate cancer (PCa)....
14.
Cui Y, Miao C, Hou C, Wang Z, Liu B
Front Oncol
. 2020 Sep;
10:1436.
PMID: 32974161
Apolipoprotein C1 (APOC1) has been proved to play a critical role in gastric, breast, lung, and pancreatic cancer. However, the relationship between APOC1 and urinary tumors remains unclear. This study...
15.
Zhang L, Gao X, Li R, Li K, Liu B, Li J, et al.
Transl Androl Urol
. 2020 Sep;
9(4):1661-1669.
PMID: 32944527
Background: Metanephric adenoma (MA) is a rare benign tumor with only several hundred cases reported worldwide to date. Herein, we retrospectively summarized the experience of diagnosis and management of ten...
16.
Tang M, Dong H, Shao P, Li J, Wang Z, Liu B
Transl Androl Urol
. 2020 Sep;
9(4):1566-1571.
PMID: 32944519
Background: The enhanced recovery after surgery (ERAS) program is focused on improving surgical outcomes and enhancing the patient experience before, during and after surgery. We performed this study to evaluate...
17.
Sun S, Dong H, Yan T, Li J, Liu B, Shao P, et al.
BMC Med Genet
. 2020 Jul;
21(1):139.
PMID: 32600280
Background: Published studies present conflicting data regarding the impact of Thrombospondin-1 (TSP-1) expression on prognosis of various cancers. We performed this meta-analysis to illustrate the preliminary predictive value of TSP-1....
18.
Cui Y, Miao C, Xu A, Wang Z, Liu B
Ann Palliat Med
. 2020 Jun;
10(2):2366-2370.
PMID: 32576002
Acinar adenocarcinoma, ductal adenocarcinoma and mucinous adenocarcinoma are the subtypes of prostate cancer (PCa). Most of the pathological types of PCa are acinar adenocarcinoma, while ductal adenocarcinoma and mucinous adenocarcinoma...
19.
Zhao Y, Zhang S, Liu B, Li J, Hong H
World J Surg Oncol
. 2020 Jun;
18(1):131.
PMID: 32552894
Background: Enhanced recovery after surgery (ERAS) protocol has been identified to be beneficial in the amount of operations such as gastrointestinal surgery. However, the efficacy and safety in robot-assisted laparoscopic...
20.
Tang M, Gao S, Zhang L, Liu B, Li J, Wang Z, et al.
Prostate
. 2020 May;
80(10):742-752.
PMID: 32449811
Background: Docetaxel is an effective first-line chemotherapy agent used in the treatment of castration-resistant prostate cancer (CRPC) patients. However, most times chemotherapy with docetaxel eventually fails due to the development...